Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4222385Aexternal-prioritypatent/DE4222385A1/en
Priority claimed from DE19924227892external-prioritypatent/DE4227892A1/en
Priority claimed from DE19934305063external-prioritypatent/DE4305063A1/en
Priority claimed from PCT/EP1993/001728external-prioritypatent/WO1994001553A1/en
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Publication of NO940797LpublicationCriticalpatent/NO940797L/en
Publication of NO940797D0publicationCriticalpatent/NO940797D0/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Oppfinnelsen beskriver fremstillingen av polypeptider med bindingsaktiviteter overfor reseptorer i den "lille rhino- virusresptorgruppe", fremgangsmåter for fremstilling av pep- tidene, anvendelsen av disse og DNA som koder for peptidene.The invention describes the preparation of polypeptides with binding activities against receptors in the "small rhino virus receptor group", methods for producing the peptides, their use and DNA encoding the peptides.
NO940797A1992-07-081994-03-07
Receptor derivatives having binding sites for human rhinovirus
NO940797D0
(en)
Isolating substances which inhibit binding of ligands to low-density lipoprotein receptors - comprises incubating LDL receptors with labelled form of ligand in presence of test substance and measuring deg. of binding
N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists